Jun-yu Zhang
Lishui, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
TIM-3 blockade reverses oncolytic vaccinia virus-induced DCs inactivation and T cells exhaustion to improve antitumor immunity and therapeutic efficacy.
Journal: Journal of experimental & clinical cancer research : CR
Published: June 11, 2025
CD20 targeted nanomedicine for GCB-diffuse large B-cell lymphoma through synergistic effects of apoptosis and ferroptosis.
Journal: Materials today. Bio
Published: February 09, 2025
Transformation of marginal zone lymphoma into high-grade B-cell lymphoma expressing terminal deoxynucleotidyl transferase: A case report.
Journal: World journal of clinical cases
Published: February 08, 2024
Successful treatment of Purpureocillium lilacinum pulmonary infection with isavuconazole: A case report.
Journal: World journal of clinical cases
Published: October 16, 2023
Reduction rate of monoclonal protein as a useful prognostic factor in standard-risk group of newly diagnosed multiple myeloma.
Journal: World journal of clinical cases
Published: March 17, 2023
Comparing the efficacy of different dexamethasone regimens for maintenance treatment of multiple myeloma in standard-risk patients non-eligible for transplantation.
Journal: World journal of clinical cases
Published: June 20, 2022
Treatment of refractory/relapsed extranodal NK/T cell lymphoma with decitabine plus anti-PD-1: A case report.
Journal: World journal of clinical cases
Published: April 09, 2022
Refractory lymphoma treated with chimeric antigen receptor T cells combined with programmed cell death-1 inhibitor: A case report.
Journal: World journal of clinical cases
Published: December 20, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026